144 related articles for article (PubMed ID: 12813901)
1. Strategies and methods in the identification of antagonists of protein-protein interactions.
Gadek TR
Biotechniques; 2003 Jun; Suppl():21-4. PubMed ID: 12813901
[TBL] [Abstract][Full Text] [Related]
2. NMR techniques for characterization of ligand binding: utility for lead generation and optimization in drug discovery.
Moore JM
Biopolymers; 1999; 51(3):221-43. PubMed ID: 10516573
[TBL] [Abstract][Full Text] [Related]
3. SAR by ILOEs: an NMR-based approach to reverse chemical genetics.
Becattini B; Pellecchia M
Chemistry; 2006 Mar; 12(10):2658-62. PubMed ID: 16121405
[TBL] [Abstract][Full Text] [Related]
4. Fragment-based screening using X-ray crystallography and NMR spectroscopy.
Jhoti H; Cleasby A; Verdonk M; Williams G
Curr Opin Chem Biol; 2007 Oct; 11(5):485-93. PubMed ID: 17851109
[TBL] [Abstract][Full Text] [Related]
5. NMR in drug discovery.
Pellecchia M; Sem DS; Wüthrich K
Nat Rev Drug Discov; 2002 Mar; 1(3):211-9. PubMed ID: 12120505
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
Lu H; Tonge PJ
Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
[TBL] [Abstract][Full Text] [Related]
7. A new strategy for improved secondary screening and lead optimization using high-resolution SPR characterization of compound-target interactions.
Huber W
J Mol Recognit; 2005; 18(4):273-81. PubMed ID: 15997470
[TBL] [Abstract][Full Text] [Related]
8. From virtuality to reality - Virtual screening in lead discovery and lead optimization: a medicinal chemistry perspective.
Rester U
Curr Opin Drug Discov Devel; 2008 Jul; 11(4):559-68. PubMed ID: 18600572
[TBL] [Abstract][Full Text] [Related]
9. Informatics and modeling challenges in fragment-based drug discovery.
Hubbard RE; Chen I; Davis B
Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
[TBL] [Abstract][Full Text] [Related]
10. The use of peptides in Diogenesis: a novel approach to drug discovery and phenomics.
Blume AJ; Beasley J; Goldstein NI
Biopolymers; 2000; 55(4):347-56. PubMed ID: 11169925
[TBL] [Abstract][Full Text] [Related]
11. Rational approaches to natural-product-based drug design.
Haustedt LO; Mang C; Siems K; Schiewe H
Curr Opin Drug Discov Devel; 2006 Jul; 9(4):445-62. PubMed ID: 16889228
[TBL] [Abstract][Full Text] [Related]
12. Fragment-based lead discovery: a chemical update.
Erlanson DA
Curr Opin Biotechnol; 2006 Dec; 17(6):643-52. PubMed ID: 17084612
[TBL] [Abstract][Full Text] [Related]
13. Affinity-based screening techniques for enhancing lead discovery.
Comess KM; Schurdak ME
Curr Opin Drug Discov Devel; 2004 Jul; 7(4):411-6. PubMed ID: 15338950
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship homology (SARAH): a conceptual framework for drug discovery in the genomic era.
Frye SV
Chem Biol; 1999 Jan; 6(1):R3-7. PubMed ID: 9889153
[TBL] [Abstract][Full Text] [Related]
15. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
16. NMR fragment screening: tackling protein-protein interaction targets.
Schade M; Oschkinat H
Curr Opin Drug Discov Devel; 2005 May; 8(3):365-73. PubMed ID: 15892252
[TBL] [Abstract][Full Text] [Related]
17. The target discovery process.
Egner U; Krätzschmar J; Kreft B; Pohlenz HD; Schneider M
Chembiochem; 2005 Mar; 6(3):468-79. PubMed ID: 15742383
[TBL] [Abstract][Full Text] [Related]
18. NMR in the acceleration of drug discovery.
Sem DS; Pellecchia M
Curr Opin Drug Discov Devel; 2001 Jul; 4(4):479-92. PubMed ID: 11727313
[TBL] [Abstract][Full Text] [Related]
19. Fragonomics: fragment-based drug discovery.
Zartler ER; Shapiro MJ
Curr Opin Chem Biol; 2005 Aug; 9(4):366-70. PubMed ID: 15925537
[TBL] [Abstract][Full Text] [Related]
20. Structural biology and drug discovery.
Congreve M; Murray CW; Blundell TL
Drug Discov Today; 2005 Jul; 10(13):895-907. PubMed ID: 15993809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
